Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$867,829
-$85,879 QoQ
Shares Held
6,869
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#1,140
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Expressive Wealth LLC holds $5,161,628 across 7 Drug Manufacturers - General names. GILD ranks #3 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
986 | $1,182,638 | |
| 2 | JNJ |
Johnson & Johnson
|
4,429 | $1,124,833 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
6,869 | $867,829 | |
| 4 | NVS |
Novartis AG
|
3,853 | $603,842 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,042 | $521,000 | |
| 6 | ABBV |
AbbVie Inc.
|
1,722 | $433,324 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,332 | $428,162 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $867,829 | 6,869 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $953,708 | 6,843 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $398,782 | 3,249 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||